soul trial oral semaglutide cardiovascular outcomes results soul trial Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes Abstract 4351008: Comparing Cardiovascular Outcomes

09-03-2025 The GLP-1 Moment: What Healthcare Marketers Can Learn from the Fastest-Growing Category in Pharma GLP-1 therapies for obesity and diabetes have ignited a movement, not just a market

The biomedical applications of nanozymes in orthopaedics based on regulating reactive oxygen species

Annual sales of GLP-1 based drugs are expected to overtake the US$ 100 billion mark by 2029 (Park)

Briefly, the islets were incubated with a glucose concentration of 2.8 mM for two sequential 45-min incubations as an initial equilibration period, where the medium was changed after each incubation

Step 1: Gather sterile supplies

One approach that is commonly used to prepare these systems is to reconstitute the protein in liposomes